ATE245160T1 - Derivate von erythromycin, ihr verfahren zur herstellung, und ihre verwendung als arzneimittel - Google Patents

Derivate von erythromycin, ihr verfahren zur herstellung, und ihre verwendung als arzneimittel

Info

Publication number: ATE245160T1
Authority: AT; Austria
Prior art keywords: erythromycin; derivatives; production; medicinal products; medicinal
Prior art date: 1998-11-24

Application number

AT99402907T

Other languages

English (en)

Inventor

Alexis Denis

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-24

Filing date

1999-11-23

Publication date

2003-08-15

1999-11-23 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2003-08-15 Application granted granted Critical

2003-08-15 Publication of ATE245160T1 publication Critical patent/ATE245160T1/de

Links

ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

AT99402907T 1998-11-24 1999-11-23 Derivate von erythromycin, ihr verfahren zur herstellung, und ihre verwendung als arzneimittel ATE245160T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9814782A FR2786188B1 (fr)	1998-11-24	1998-11-24	Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Publications (1)

Publication Number	Publication Date
ATE245160T1 true ATE245160T1 (de)	2003-08-15

Family

ID=9533122

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99402907T ATE245160T1 (de)	1998-11-24	1999-11-23	Derivate von erythromycin, ihr verfahren zur herstellung, und ihre verwendung als arzneimittel

Country Status (24)

Country	Link
US (2)	US6440941B1 (de)
EP (1)	EP1004592B1 (de)
JP (1)	JP2000159790A (de)
KR (1)	KR100587445B1 (de)
CN (1)	CN1165546C (de)
AR (1)	AR021388A1 (de)
AT (1)	ATE245160T1 (de)
AU (1)	AU772171B2 (de)
BR (1)	BR9905735A (de)
CA (1)	CA2290136C (de)
DE (1)	DE69909577T2 (de)
DK (1)	DK1004592T3 (de)
ES (1)	ES2198867T3 (de)
FR (1)	FR2786188B1 (de)
HU (1)	HUP9904392A3 (de)
IL (1)	IL133101A (de)
MX (1)	MXPA99010813A (de)
NO (1)	NO314729B1 (de)
PL (1)	PL336736A1 (de)
PT (1)	PT1004592E (de)
RU (1)	RU2237672C2 (de)
TR (1)	TR199902888A3 (de)
TW (1)	TWI247747B (de)
ZA (1)	ZA997176B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2786188B1 (fr) *	1998-11-24	2002-10-31	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
DK1147121T3 (da) *	1999-01-27	2004-04-13	Pfizer Prod Inc	Ketolidantibiotika
EE200100613A (et)	1999-05-24	2003-02-17	Pfizer Products Inc.	13-metüülerütromütsiini derivaadid
EP1167376B1 (de)	2000-06-30	2004-07-14	Pfizer Products Inc.	Makrolid-Antibiotika
US7601695B2 (en)	2003-03-10	2009-10-13	Optimer Pharmaceuticals, Inc.	Antibacterial agents
FR2862647B1 (fr) *	2003-11-25	2008-07-04	Aventis Pharma Sa	Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
WO2006080954A1 (en) *	2004-07-28	2006-08-03	Ranbaxy Laboratories Limited	Ketolide derivatives as antibacterial agents
AU2008316830B2 (en)	2007-10-25	2016-03-17	Cempra Pharmaceuticals, Inc.	Process for the preparation of macrolide antibacterial agents
US8552162B2 (en) *	2008-05-09	2013-10-08	Enanta Pharmaceuticals, Inc.	Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
CN107854477A (zh)	2008-10-24	2018-03-30	森普拉制药公司	使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en)	2009-06-12	2018-04-10	Cempra Pharmaceuticals, Inc.	Compounds and methods for treating inflammatory diseases
US9480679B2 (en)	2009-09-10	2016-11-01	Cempra Pharmaceuticals, Inc.	Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr)	2010-03-22	2016-03-25	Cempra Pharmaceuticals Inc	Kristalne forme makrolida i njihova uporaba
BR112012029586A2 (pt)	2010-05-20	2016-08-02	Cempra Pharmaceuticals Inc	processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko) *	2010-09-10	2013-11-04	셈프라 파마슈티컬스, 인크.	질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
BR112013009823A2 (pt)	2010-10-22	2016-07-05	Bayer Ip Gmbh	novos compostos heterocíclicos como pesticidas
WO2013148891A1 (en)	2012-03-27	2013-10-03	Cempra Pharmaceuticals, Inc.	Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en)	2013-03-14	2014-09-25	Cempra Pharmaceuticals, Inc.	Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en)	2013-03-15	2018-08-09	Cempra Pharmaceuticals, Inc.	Convergent processes for preparing macrolide antibacterial agents
CN106432383A (zh) *	2016-09-14	2017-02-22	重庆两江药物研发中心有限公司	索利霉素及其中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4182895A (en) *	1976-12-20	1980-01-08	Sterling Drug Inc.	1-Amino-lower-alkyl-3,4-diphenyl-1H-pyrazoles
CA1098527A (en) *	1976-12-20	1981-03-31	Denis M. Bailey	1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
JPH04234891A (ja) *	1990-03-05	1992-08-24	Fujisawa Pharmaceut Co Ltd	新規セフェム化合物およびその塩
FR2697524B1 (fr) *	1992-11-05	1994-12-23	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) *	1992-11-05	1996-06-18	Roussel Uclaf	Erythromycin derivatives
FR2718450B1 (fr) *	1994-04-08	1997-01-10	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) *	1994-05-03	1996-07-12	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) *	1994-12-09	1997-01-17	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) *	1995-12-22	1998-01-30	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
KR20010013660A (ko) *	1997-06-11	2001-02-26	실버스타인 아써 에이.	9-옥심 에리트로마이신 유도체
FR2786188B1 (fr) *	1998-11-24	2002-10-31	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

1998
- 1998-11-24 FR FR9814782A patent/FR2786188B1/fr not_active Expired - Fee Related
1999
- 1999-11-16 TW TW088119939A patent/TWI247747B/zh not_active IP Right Cessation
- 1999-11-17 AU AU59522/99A patent/AU772171B2/en not_active Expired
- 1999-11-18 ZA ZA9907176A patent/ZA997176B/xx unknown
- 1999-11-18 CA CA2290136A patent/CA2290136C/fr not_active Expired - Lifetime
- 1999-11-18 US US09/442,681 patent/US6440941B1/en not_active Expired - Lifetime
- 1999-11-22 JP JP11331141A patent/JP2000159790A/ja active Pending
- 1999-11-23 IL IL133101A patent/IL133101A/en not_active IP Right Cessation
- 1999-11-23 NO NO19995745A patent/NO314729B1/no unknown
- 1999-11-23 PT PT99402907T patent/PT1004592E/pt unknown
- 1999-11-23 DE DE69909577T patent/DE69909577T2/de not_active Expired - Lifetime
- 1999-11-23 MX MXPA99010813A patent/MXPA99010813A/es active IP Right Grant
- 1999-11-23 CN CNB99127394XA patent/CN1165546C/zh not_active Expired - Lifetime
- 1999-11-23 AT AT99402907T patent/ATE245160T1/de active
- 1999-11-23 KR KR1019990052014A patent/KR100587445B1/ko not_active Expired - Lifetime
- 1999-11-23 HU HU9904392A patent/HUP9904392A3/hu unknown
- 1999-11-23 RU RU99125547A patent/RU2237672C2/ru not_active IP Right Cessation
- 1999-11-23 EP EP99402907A patent/EP1004592B1/de not_active Expired - Lifetime
- 1999-11-23 DK DK99402907T patent/DK1004592T3/da active
- 1999-11-23 ES ES99402907T patent/ES2198867T3/es not_active Expired - Lifetime
- 1999-11-24 TR TR1999/02888A patent/TR199902888A3/tr unknown
- 1999-11-24 BR BR9905735-2A patent/BR9905735A/pt active Search and Examination
- 1999-11-24 AR ARP990105985A patent/AR021388A1/es not_active Application Discontinuation
- 1999-11-24 PL PL99336736A patent/PL336736A1/xx not_active Application Discontinuation
2002
- 2002-07-02 US US10/188,394 patent/US6664398B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO995745D0 (no)	1999-11-23
EP1004592B1 (de)	2003-07-16
TWI247747B (en)	2006-01-21
NO314729B1 (no)	2003-05-12
IL133101A (en)	2007-02-11
EP1004592A1 (de)	2000-05-31
CA2290136C (fr)	2010-07-20
MXPA99010813A (es)	2005-09-08
KR100587445B1 (ko)	2006-06-08
DK1004592T3 (da)	2003-10-27
PL336736A1 (en)	2000-06-05
US6440941B1 (en)	2002-08-27
ES2198867T3 (es)	2004-02-01
TR199902888A2 (xx)	2000-06-21
FR2786188A1 (fr)	2000-05-26
DE69909577T2 (de)	2004-06-03
CA2290136A1 (fr)	2000-05-24
AR021388A1 (es)	2002-07-17
AU5952299A (en)	2000-05-25
RU2237672C2 (ru)	2004-10-10
ZA997176B (en)	2000-11-20
HUP9904392A3 (en)	2001-08-28
DE69909577D1 (de)	2003-08-21
TR199902888A3 (tr)	2000-06-21
BR9905735A (pt)	2000-08-08
NO995745L (no)	2000-05-25
HU9904392D0 (en)	2000-01-28
CN1263101A (zh)	2000-08-16
KR20000057017A (ko)	2000-09-15
PT1004592E (pt)	2003-12-31
US20030050254A1 (en)	2003-03-13
HUP9904392A2 (hu)	2000-05-28
AU772171B2 (en)	2004-04-08
IL133101A0 (en)	2001-03-19
FR2786188B1 (fr)	2002-10-31
JP2000159790A (ja)	2000-06-13
US6664398B2 (en)	2003-12-16
CN1165546C (zh)	2004-09-08

Legal Events

Date

Code

Title

Description

2004-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1004592

Country of ref document: EP

Publication	Publication Date	Title
ATE172203T1 (de)	1998-10-15	Erythromycinderivate, ihre verfahren zur herstellung und ihre verwendung als arzneimittel
ATE234853T1 (de)	2003-04-15	Erythromycin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel
ATE217633T1 (de)	2002-06-15	Erythramicin-derivate, ihre verfahren zur herstellung und ihre verwendung als arzneimittel
ATE247099T1 (de)	2003-08-15	Sulfonamid-derivate, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel
ATE430749T1 (de)	2009-05-15	Xanthinderivate verwendung als arzneimittel sowie deren verfahren zur deren herstellung
ATE299148T1 (de)	2005-07-15	Substituierte isochinolin-3-carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel
ATE522213T1 (de)	2011-09-15	Fünfgliedrige-heteroringderivate , ihre herstellung und ihre verwendung als arzneimittel
ATE239712T1 (de)	2003-05-15	Disubstituierte bicyclische heterocyclen, ihre herstellung und ihre verwendung als arzneimittel
ATE265424T1 (de)	2004-05-15	Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69909577D1 (de)	2003-08-21	Derivate von Erythromycin, ihr Verfahren zur Herstellung, und ihre Verwendung als Arzneimittel
ATE222236T1 (de)	2002-08-15	Neue guanidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE232879T1 (de)	2003-03-15	Erythromycin-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE212034T1 (de)	2002-02-15	Derivate von 5-0-desosaminyl-6-0-methyl erythronolid a, ihre verfahren zur herstellung und verwendung zur herstellung von arzneimitteln
DE69626682D1 (de)	2003-04-17	Verfahren zur herstellung von guanidinderivaten, zwischenprodukte dafür und ihre herstellung
ATE301645T1 (de)	2005-08-15	Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69901098D1 (de)	2002-05-02	Hypnotische beta-carbolin derivate verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69804212D1 (de)	2002-04-18	Verfahren und zwischenprodukte zur herstellung substituierter indazolderivate
DE60012750D1 (de)	2004-09-09	Neue xanthon derivate, deren herstellung und verwendung als arzneimittel
DE69716284D1 (de)	2002-11-14	Erythromycin-derivate, verfahren zur herstellung und verwendung als arzneimittel
ATE331706T1 (de)	2006-07-15	Coniosetin und derivate davon, verfahren zur herstellung und verwendung derselben
ATE224890T1 (de)	2002-10-15	Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin- 0-ole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE411979T1 (de)	2008-11-15	Derivate von c2-substituierten indan-1-ol- systemen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69521142D1 (de)	2001-07-05	6-methoxy-1h-benzotriazol-5-carboxamid-derivate, verfahren zur herstellung und diese enthaltende arzneimittel
ATE231154T1 (de)	2003-02-15	Derivate von aryl- oder heteroaryl- quinolinylphosphonsäuren, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
ATE429418T1 (de)	2009-05-15	C2-substituierte indan-1-ole und ihre derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel